Proteolysis-targeting chimeras in breast cancer therapy

Future Med Chem. 2020 Dec;12(24):2175-2177. doi: 10.4155/fmc-2020-0279. Epub 2020 Nov 23.
No abstract available

Keywords: E3 ligase; PROTACs; breast cancer; degraded protein.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Chimera / metabolism*
  • Female
  • Humans
  • Proteolysis / drug effects*

Substances

  • Antineoplastic Agents